Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-11Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-05-08Employing Near Infrared Spectroscopy to Non-invasively Assess Changes in Cerebral Perfusion in Response to Subthalamic Deep Brain Stimulation
-
CLINICAL_TRIALS study record update · 2017-05-03Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Continuous Subcutaneous Infusion in Parkinson's Disease Patients With Refractory Visual Hallucinations
-
CLINICAL_TRIALS study record update · 2017-05-03A 10-year Observational Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist
-
CLINICAL_TRIALS study record update · 2017-04-27Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-18A Phase I/II, Open-Label Study to Assess the Safety and Efficacy of Striatum Transplantation of Human Embryonic Stem Cells-derived Neural Precursor Cells in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-04-18An Open Label Conversion Study of Carbidopa-Levodopa (CD-LD) Extended-Release Taken Alone or in Combination With CD-LD Immediate Release to IPX066 Followed by an Open-Label Extension Safety Study of IPX066 in Advanced PD
-
CLINICAL_TRIALS study record update · 2017-04-17[18F]Flubatine: a Novel Biomarker of Cholinergic a4ß2 Nicotinic Receptors and Cognition in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-04-13Repetitive Transcranial Magnetic Stimulation (rTMS) for Motor and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
-
CLINICAL_TRIALS study record update · 2017-04-13A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-04-07A Phase IV Randomized, Double-Blind, Placebo-Controlled, Crossover Single Site Study Of Exelon® Patch (Rivastigmine Transdermal System) For Mild Cognitive Impairment In Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-03-31Contribution of Magnetic Resonance Imaging (Diffusion Tensor Imaging and Magnetic Susceptibility Imaging and Resting Activation Imaging) in the Diagnosis of Parkinsonian Syndromes in Elderly Subjects.
-
CLINICAL_TRIALS study record update · 2017-03-31A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
-
CLINICAL_TRIALS study record update · 2017-03-29Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2017-03-27A Phase 1b, 2-period, Open Label, Multicenter, Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06649751 In Subjects With Parkinson's Disease And Motor Fluctuations
-
CLINICAL_TRIALS study record update · 2017-03-24Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-03-22Caffeine as a Therapeutic Agent in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-03-21Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-03-21Double-Blind Trial of Variable Frequency Stimulation for Freezing of Gait in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-03-15Phase 3 Study of KW-6500 (Safety Study for Extended Long-Term Self-Injection at Home in Patients With Parkinson's Disease)
-
CLINICAL_TRIALS study record update · 2017-03-15Phase 3 Study of KW-6500 (Safety Study for Long-Term Self-Administration at Home in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-03-10Onabotulinum Toxin Type A (BTX-A) For Treatment of Neurogenic Overactive Bladder Due to Parkinson's Disease: Safety and Efficacy
-
CLINICAL_TRIALS study record update · 2017-03-03Motor, Non-motor and Genetic Determinants of Progression and Complications in Parkinson's Disease: A Multicenter Cohort Study in Mexican Population (ReMePArk)
-
CLINICAL_TRIALS study record update · 2017-03-03Phase 3 Study of KW-6500 (Placebo-Controlled Double-Blind Crossover Comparative Study in Patients With Parkinson's Disease)
-
CLINICAL_TRIALS study record update · 2017-02-23ClinicalTrials.gov study NCT01534650